Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Sell Seeing Machines Ltd. NPV (DI) (SEE) by Steve Moore in ShareProphets
- Sell Quiz (QUIZ) by Steve Moore in ShareProphets
- Buy Croda International (CRDA) by Tom Winnifrith in ShareProphets
- Buy British American Tobacco (BATS) by Mark David Hartley in The Motley Fool
- Buy Diageo (DGE) by Stephen Wright in The Motley Fool
- Buy Taylor Wimpey (TW.) by Harvey Jones in The Motley Fool
- Avoid Inspects Group (SPEC) by Steve Moore in ShareProphets
- Buy Zotefoams (ZTF) by Hot Stock Rockets in ShareProphets
- Neutral Ceres Power Holdings (CWR) by Goldman Sachs
- Sell Bunzl (BNZL) by Goldman Sachs
- Buy Anglo American (AAL) by Stephen Wright in The Motley Fool
- Hold AstraZeneca (AZN) by Ben McPoland in The Motley Fool
- Hold BAE Systems (BA.) by Ben McPoland in The Motley Fool
- Buy Land Securities Group (LAND) by Robert Stephens (Telegraph) in The Telegraph - Questor
- Buy Greggs (GRG) by Ben McPoland in The Motley Fool
- Sell Inspired (INSE) by Steve Moore in ShareProphets
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
Verona Pharma (VRP) Share Price
Health Care Sector
NOTE: This is based on 21 open tips for Verona Pharma (VRP)
| Latest Bid : 50.00p | Latest Ask : 60.00p |
| High Today : 57.50p | Low Today : 50.00p |
| This Years High : 101.50p | This Years Low : 31.50p |
| Volume : 51,792 | MKT Cap : £227.7M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
13/02/2017 – Stock Consolidation 50.000:1.000
Verona Pharma (VRP) Overview
Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe coughVerona Pharma (VRP) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Shore Capital | Premium Only | 2020-04-30 09:55:00 30/04/2020 | -0.90% |
| Buy | Shore Capital | Premium Only | 2020-02-03 14:45:00 03/02/2020 | 4.76% |
| Buy | Shore Capital | Premium Only | 2019-08-05 14:50:00 05/08/2019 | 20.88% |
| Buy | Shore Capital | Premium Only | 2019-06-04 15:00:00 04/06/2019 | -7.56% |
| Buy | Shore Capital | Premium Only | 2019-03-04 08:30:00 04/03/2019 | 0.00% |
Verona Pharma (VRP) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Armistice Capital LLC | 0.58% | 05/07/2024 |
| Latest Bid : 50.00p | Latest Ask : 60.00p |
| High Today : 57.50p | Low Today : 50.00p |
| This Years High : 101.50p | This Years Low : 31.50p |
| Volume : 51,792 | MKT Cap : £227.7M |
Verona Pharma Overview
Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe coughNOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verona Pharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Shore Capital | Premium Only | 2020-04-30 09:55:00 30/04/2020 | -0.90% |
| Buy | Shore Capital | Premium Only | 2020-02-03 14:45:00 03/02/2020 | 4.76% |
| Buy | Shore Capital | Premium Only | 2019-08-05 14:50:00 05/08/2019 | 20.88% |
| Buy | Shore Capital | Premium Only | 2019-06-04 15:00:00 04/06/2019 | -7.56% |
| Buy | Shore Capital | Premium Only | 2019-03-04 08:30:00 04/03/2019 | 0.00% |
Stock Splits and Consolidations
13/02/2017 – Stock Consolidation 50.000:1.000